Statera Biopharma (STAB) Competitors $0.0002 0.00 (-33.33%) (As of 11:55 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends STAB vs. CALA, SCPS, ARDS, EVLO, GNCA, AMPE, CMRA, EFTR, ONCSQ, and ATNFWShould you be buying Statera Biopharma stock or one of its competitors? The main competitors of Statera Biopharma include Calithera Biosciences (CALA), Scopus BioPharma (SCPS), Aridis Pharmaceuticals (ARDS), Evelo Biosciences (EVLO), Genocea Biosciences (GNCA), Ampio Pharmaceuticals (AMPE), Comera Life Sciences (CMRA), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), and 180 Life Sciences (ATNFW). These companies are all part of the "pharmaceutical products" industry. Statera Biopharma vs. Calithera Biosciences Scopus BioPharma Aridis Pharmaceuticals Evelo Biosciences Genocea Biosciences Ampio Pharmaceuticals Comera Life Sciences eFFECTOR Therapeutics OncoSec Medical 180 Life Sciences Statera Biopharma (NASDAQ:STAB) and Calithera Biosciences (NASDAQ:CALA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, valuation, analyst recommendations, media sentiment, dividends, profitability and risk. Does the MarketBeat Community favor STAB or CALA? Calithera Biosciences received 341 more outperform votes than Statera Biopharma when rated by MarketBeat users. CompanyUnderperformOutperformStatera BiopharmaN/AN/ACalithera BiosciencesOutperform Votes34157.41% Underperform Votes25342.59% Do analysts rate STAB or CALA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Statera Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ACalithera Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Which has more volatility & risk, STAB or CALA? Statera Biopharma has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500. Comparatively, Calithera Biosciences has a beta of -1.12, indicating that its stock price is 212% less volatile than the S&P 500. Which has better valuation & earnings, STAB or CALA? Calithera Biosciences has higher revenue and earnings than Statera Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStatera Biopharma$1.49M0.01-$101.85MN/AN/ACalithera Biosciences$9.75M0.00-$39.65MN/AN/A Is STAB or CALA more profitable? Company Net Margins Return on Equity Return on Assets Statera BiopharmaN/A N/A N/A Calithera Biosciences N/A N/A N/A Does the media prefer STAB or CALA? In the previous week, Calithera Biosciences had 1 more articles in the media than Statera Biopharma. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Statera Biopharma. Statera Biopharma's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score. Company Overall Sentiment Statera Biopharma Neutral Calithera Biosciences Neutral SummaryCalithera Biosciences beats Statera Biopharma on 4 of the 6 factors compared between the two stocks. Ad Unstoppable Prosperity[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about CLICK HERE TO RSVP Get Statera Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for STAB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STAB vs. The Competition Export to ExcelMetricStatera BiopharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$11,000.00$6.74B$5.02B$8.44BDividend YieldN/A7.94%7.49%4.16%P/E RatioN/A11.61127.0816.62Price / Sales0.01289.441,683.1877.41Price / CashN/A46.0936.9033.53Price / BookN/A5.284.585.21Net Income-$101.85M$150.62M$113.81M$223.74M7 Day PerformanceN/A0.30%111.02%2.82%1 Month PerformanceN/A16.75%125.11%8.93%1 Year PerformanceN/A37.44%155.23%29.44% Statera Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STABStatera BiopharmaN/A$0.00-33.3%N/A-97.0%$11,000.00$1.49M0.0020CALACalithera BiosciencesN/A$0.01+16.7%N/A-76.7%$34,000.00$9.75M0.0060News CoverageGap UpSCPSScopus BioPharmaN/A$0.00flatN/AN/A$17,000.00N/A0.009ARDSAridis Pharmaceuticals0.895 of 5 stars$0.00+50.0%$2.00+666,566.7%-99.8%$16,000.00$3.09M0.0030Gap UpEVLOEvelo BiosciencesN/A$0.00+33.3%N/A-99.9%$8,000.00N/A0.00120Gap UpGNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst ForecastAMPEAmpio PharmaceuticalsN/A$0.00flatN/A-99.9%$3,000.00N/A0.0020CMRAComera Life SciencesN/A$0.00-50.0%N/AN/A$3,000.00$630,000.000.002Gap DownEFTReFFECTOR TherapeuticsN/A$0.00flat$24.00+5,999,900.0%-100.0%$2,000.00$3.55M0.0010ONCSQOncoSec MedicalN/A$0.00+∞N/AN/A$1,000.00N/A0.0040Gap UpATNFW180 Life SciencesN/A$0.01+15.0%N/A+0.0%$0.00N/A0.007Positive NewsGap Up Related Companies and Tools Related Companies Calithera Biosciences Competitors Scopus BioPharma Competitors Aridis Pharmaceuticals Competitors Evelo Biosciences Competitors Genocea Biosciences Competitors Ampio Pharmaceuticals Competitors Comera Life Sciences Competitors eFFECTOR Therapeutics Competitors OncoSec Medical Competitors 180 Life Sciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:STAB) was last updated on 11/4/2024 by MarketBeat.com Staff From Our PartnersCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a ...Golden Crest | Sponsored[Charles Payne Live Event] Click to Confirm Your RSVPThe Blueprint to Protect Your Portfolio Charles Payne reveals a strategy few investors know about Unstoppable Prosperity | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredA new way to play the AI boom (act before November 19)There's a new way to play the $15 trillion AI boom. And it's so simple - you can do it right now with as li...Behind the Markets | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Statera Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Statera Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free STAB Stock Alerts